Jamaica Plain, MA, United States of America

Daniel G Jay

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Tufts University, Harvard College. Active years: 2002-2015.

USPTO Granted Patents = 4 

% Patents Active = 75.0



Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Brighton, MA (US) (2002 - 2013)
  • Jamaica Plain, MA (US) (2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel G Jay

Introduction

Daniel G Jay is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of cancer research through his innovative inventions. With a total of 4 patents, his work focuses on the development of inhibitors that target extracellular Hsp90, which plays a crucial role in tumor cell invasiveness.

Latest Patents

One of Daniel G Jay's latest patents involves inhibitors of extracellular Hsp90. This invention describes how the inhibition of extracellular Hsp90 can lead to a reduction in the invasiveness of tumor cells. Furthermore, it relates to the use of molecules that inhibit extracellular Hsp90 function for the manufacture of a medicament aimed at treating or preventing the invasion and/or metastatic potential of cancer cells. This innovative approach has the potential to significantly impact cancer treatment strategies.

Career Highlights

Throughout his career, Daniel G Jay has worked with prestigious institutions such as Tufts University and Harvard College. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field, further enhancing his research and inventions.

Collaborations

Daniel has collaborated with notable individuals such as Takashi Sakurai and Brenda K Eustace. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Daniel G Jay's innovative work in developing inhibitors of extracellular Hsp90 showcases his commitment to advancing cancer treatment. His contributions to the field are significant and reflect his dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…